Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2023
Evidence-Based Guide to Using Artificial Introns for Tissue-Specific Knockout in Mice, Elena McBeath, Keigi Fujiwara, and Marie-Claude Hofmann
Interaction between Myelodysplasia-Related Gene Mutations and Ontogeny in Acute Myeloid Leukemia, Joseph G W McCarter, David Nemirovsky, Christopher A Famulare, et al.
MMP9 Clears the Way for Metastatic Cell Penetration Across the Blood-Brain Barrier, Joseph H McCarty
Intraoperative Cortical Localization of Music and Language Reveals Signatures of Structural Complexity In Posterior Temporal Cortex, Meredith J McCarty, Elliot Murphy, Xavier Scherschligt, et al.
Leveraging a Surrogate Outcome to Improve Inference on a Partially Missing Target Outcome, Zachary R McCaw, Sheila M Gaynor, Ryan Sun, et al.
How Influential Are Medical School Curriculum and Other Medical School Characteristics in Students' Selecting Pathology as a Specialty?, Cindy B McCloskey, Mark Brissette, John Michael Childs, et al.
The Need for SPACE to Plan the Future for Spondyloarthritis, Louise D McCullough
Predicting Severity of Radiation Induced Lymphopenia in Individual Proton Therapy Patients for Varying Dose Rate and Fractionation Using Dynamic 4-Dimensional Blood Flow Simulations, Lucas McCullum, Jungwook Shin, Stella Xing, et al.
Prospective Evaluation of In Vivo and Phantom Repeatability and Reproducibility of Diffusion-Weighted MRI Sequences on 15 T MRI-Linear Accelerator (MR-Linac) and MR Simulator Devices for Head and Neck Cancers, Brigid A McDonald, Travis Salzillo, Samuel Mulder, et al.
Outcomes in ANCA-Associated Vasculitis in Scotland: Validation of the Renal Risk Score in a Complete National Cohort, Dominic P McGovern, Jennifer S Lees, Jamie P Traynor, et al.
Widespread BRCA1/2-Independent Homologous Recombination Defects Are Caused by Alterations in RNA-Binding Proteins, Daniel J McGrail, Yang Li, Roger S Smith, et al.
Feature Selection for Support Vector Regression Using a Genetic Algorithm, Shannon B McKearnan, David M Vock, G Elisabeta Marai, et al.
Model-Informed Drug Development of Autologous Car-T Cell Therapy: Strategies to Optimize Car-T Cell Exposure Leveraging Cell Kinetic/Dynamic Modeling, Anna M Mc Laughlin, Peter A Milligan, Cassian Yee, et al.
Letter to the Editor: Quality Criteria for Computational Models Predicting Individual Outcomes in CAR-T Cell Therapy, Anna M Mc Laughlin and Cassian Yee
Contribution of the Oral and Gastrointestinal Microbiomes to Bloodstream Infections in Leukemia Patients, Stephanie McMahon, Pranoti Sahasrabhojane, Jiwoong Kim, et al.
Antibody Toolkit to Investigate eEF1A Methylation Dynamics in mRNA Translation Elongation, Robert Mealey-Farr, Jinho Jeong, Juhyung Park, et al.
Mass Spectrometry Based Biomarkers for Early Detection of Hcc Using a Glycoproteomic Approach, Yehia Mechref, Wenjing Peng, Sakshi Gautam, et al.
Corrigendum to “Epstein-Barr-Virus-Positive Large B-Cell Lymphoma Associated With Breast Implants: An Analysis of Eight Patients Suggesting a Possible Pathogenetic Relationship” [Modern Pathology 34 (2021) 2154–2167], L Jeffrey Medeiros, Mario L Marques-Piubelli, Valentina F I Sangiorgio, et al.
Clinical Insights Into Small Cell Lung Cancer: Tumor Heterogeneity, Diagnosis, Therapy, and Future Directions, Zsolt Megyesfalvi, Carl M Gay, Helmut Popper, et al.
Unfolding the Secrets of Small Cell Lung Cancer Progression: Novel Approaches and Insights Through Rapid Autopsies, Zsolt Megyesfalvi, Simon Heeke, Benjamin J Drapkin, et al.
Characterizing the Interplay of Treatment Parameters and Complexity and Their Impact on Performance on an IROC IMRT Phantom Using Machine Learning, Hunter Mehrens, Andrea Molineu, Nadia Hernandez, et al.
Analysis of Performance and Failure Modes of the IROC Proton Liver Phantom, Hunter Mehrens, Paige Taylor, Paola Alvarez, et al.
HLA Factors versus Non-HLA Factors for Haploidentical Donor Selection, Rohtesh S Mehta, Kai Cao, Rima M Saliba, et al.
ZRANB1 Is an NBS1 Deubiquitinase and a Potential Target To Overcome Radioresistance and PARP Inhibitor Resistance in Triple-Negative Breast Cancer, Ying Mei, Qinglei Hang, Hongqi Teng, et al.
ZRANB1 Is an NBS1 Deubiquitinase and a Potential Target to Overcome Radioresistance and PARP Inhibitor Resistance in Triple-Negative Breast Cancer, Ying Mei, Qinglei Hang, Hongqi Teng, et al.